Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Soares A, Sokumbi O, 2021. Recent updates in the treatment of erythema multiforme. Medicina (Kaunas) 57: 921.
-
2.
Huff JC, Weston WL, Tonnesen MG, 1983. Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 8: 763–775.
-
3.
Su SB, Chang HL, Chen AK, 2020. Current status of mumps virus infection: Epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health 17: 1686.
-
4.
Henle G, Henle W, 1948. Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med 88: 223–232.
-
5.
Hviid A, Rubin S, Mühlemann K, 2008. Mumps. Lancet 371: 932–944.
-
6.
Lam E, Rosen JB, Zucker JR, 2020. Mumps: An update on outbreaks, vaccine efficacy, and genomic diversity. Clin Microbiol Rev 33: e00151-19.
-
7.
Trayes KP, Love G, Studdiford JS, 2019. Erythema multiforme: Recognition and management. Am Fam Physician 100: 82–88.
-
8.
Gargiulo L, Pavia G, Facheris P, Valenti M, Sacrini F, Narcisi A, Borroni R, Constanzo A, Mancini LL, 2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever. Dermatol Ther 33: e13779.
-
9.
Bernardini ML, D’Angelo G, Oggiano N, Campanati A, Ficcadenti A, Coppa GV, Offidani A, 2006. Erythema multiforme following live attenuated trivalent measles-mumps-rubella vaccine. Acta Derm Venereol 86: 359–360.
-
10.
Kaur S, Handa S, 2008. Erythema multiforme following vaccination in an infant. Indian J Dermatol Venereol Leprol 74: 251–253.
-
11.
Yousefian M, Khadivi A, 2023. Occurrence of erythema multiforme following COVID-19 vaccination: A review. Clin Exp Vaccine Res 12: 87–96.
-
12.
Wetter DA, Davis MDP, 2010. Recurrent erythema multiforme: Clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 62: 45–53.
-
13.
Huff JC, 1985. Erythema multiforme. Dermatol Clin 3: 141–152.
-
14.
Deivanayagi M, Narmadha C, Elamparithi B, Sakthi S, Thennarasu AR, 2024. Oral erythema multiforme: A case report and review of diagnostic, therapeutic and prognostic challenges. Cureus 16: e66749.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 20472 | 20472 | 708 |
| Full Text Views | 38 | 38 | 3 |
| PDF Downloads | 9 | 9 | 4 |
Erythema Multiforme Secondary to Mumps
LakshmiPrasad Lakshmipathi
LakshmiPrasad Lakshmipathi
Sri Venkateshwaraa Medical College Hospital and Research Centre, Ariyur, India
Search for other papers by LakshmiPrasad Lakshmipathi in
Current site
Google Scholar
PubMed
Search for other papers by LakshmiPrasad Lakshmipathi in
Current site
Google Scholar
PubMed
Yogindher Singh
Yogindher Singh
Sri Venkateshwaraa Medical College Hospital and Research Centre, Ariyur, India
Search for other papers by Yogindher Singh in
Current site
Google Scholar
PubMed
Search for other papers by Yogindher Singh in
Current site
Google Scholar
PubMed
Manobalan Karunanandhan
manobalankaruna@gmail.com
Manobalan Karunanandhan
Sri Venkateshwaraa Medical College Hospital and Research Centre, Ariyur, India
Search for other papers by Manobalan Karunanandhan in
Current site
Google Scholar
PubMed
Search for other papers by Manobalan Karunanandhan in
Current site
Google Scholar
PubMed
ABSTRACT.
Erythema multiforme (EMF), an immune-mediated disorder, presents with either cutaneous or mucosal lesions, or both. Although associated with multiple etiologies, the majority are attributed to infectious etiologies and drugs. In this case report, we describe a case of EMF secondary to a very uncommon etiology—mumps. A 22-year-old male presented with targetoid lesions on bilateral palms, the upper and lower extremities, and the trunk. He also had a few targetoid lesions on the lips and glans penis. The patient reported an episode of fever with parotid enlargement and tenderness 1 week before the onset of skin lesions. A serological investigation revealed significantly elevated IgM antibody titers to mumps. Erythema multiforme has many triggering factors, with infections such as herpes simplex virus being the most common, followed by drugs like penicillin, cephalosporins, and others. This case report shows that, in addition to the most common causes, other viral infectious etiologies should also be considered as possible triggers.
- Supplemental Materials (PDF 453.78 KB)
Author Notes
Current contact information: LakshmiPrasad Lakshmipathi, Yogindher Singh, and Manobalan Karunanandhan, Department of Dermatology, Sri Venkateshwaraa Medical College Hospital and Research Centre, Ariyur, India, E-mails: laxmiprasad471@gmail.com, yogindher@gmail.com, and manobalankaruna@gmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Soares A, Sokumbi O, 2021. Recent updates in the treatment of erythema multiforme. Medicina (Kaunas) 57: 921.
-
2.
Huff JC, Weston WL, Tonnesen MG, 1983. Erythema multiforme: A critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 8: 763–775.
-
3.
Su SB, Chang HL, Chen AK, 2020. Current status of mumps virus infection: Epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health 17: 1686.
-
4.
Henle G, Henle W, 1948. Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med 88: 223–232.
-
5.
Hviid A, Rubin S, Mühlemann K, 2008. Mumps. Lancet 371: 932–944.
-
6.
Lam E, Rosen JB, Zucker JR, 2020. Mumps: An update on outbreaks, vaccine efficacy, and genomic diversity. Clin Microbiol Rev 33: e00151-19.
-
7.
Trayes KP, Love G, Studdiford JS, 2019. Erythema multiforme: Recognition and management. Am Fam Physician 100: 82–88.
-
8.
Gargiulo L, Pavia G, Facheris P, Valenti M, Sacrini F, Narcisi A, Borroni R, Constanzo A, Mancini LL, 2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever. Dermatol Ther 33: e13779.
-
9.
Bernardini ML, D’Angelo G, Oggiano N, Campanati A, Ficcadenti A, Coppa GV, Offidani A, 2006. Erythema multiforme following live attenuated trivalent measles-mumps-rubella vaccine. Acta Derm Venereol 86: 359–360.
-
10.
Kaur S, Handa S, 2008. Erythema multiforme following vaccination in an infant. Indian J Dermatol Venereol Leprol 74: 251–253.
-
11.
Yousefian M, Khadivi A, 2023. Occurrence of erythema multiforme following COVID-19 vaccination: A review. Clin Exp Vaccine Res 12: 87–96.
-
12.
Wetter DA, Davis MDP, 2010. Recurrent erythema multiforme: Clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007. J Am Acad Dermatol 62: 45–53.
-
13.
Huff JC, 1985. Erythema multiforme. Dermatol Clin 3: 141–152.
-
14.
Deivanayagi M, Narmadha C, Elamparithi B, Sakthi S, Thennarasu AR, 2024. Oral erythema multiforme: A case report and review of diagnostic, therapeutic and prognostic challenges. Cureus 16: e66749.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 20472 | 20472 | 708 |
| Full Text Views | 38 | 38 | 3 |
| PDF Downloads | 9 | 9 | 4 |